Nareg Varjabedian , Regulatory Affairs Team Lead at ClinChoice, shared a post on LinkedIn: Emerging Clinical Insight: GLP-1 Agonists May Interfere with FDG PET-CT Imaging In recent years, GLP-1 receptor agonistsincluding semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro)have revolutionized the management of type 2 diabetes and obesity
Conflict of interest The authors declare that the study was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
Eva Sheie (10:04): I know I never forget my numbers, but everybody's different
Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2002) 93:68898
You can discuss these options with your doctor to help choose the most appropriate test for you
Safe medication use: Only a clinic can prescribe and monitor FDA-approved medications such as Semaglutide, Tirzepatide, or Phentermine safely